Total Payments
$12,343
2024 Payments
$2,058
Companies
65
Transactions
546
Medicare Patients
11,554
Medicare Billing
$649,199
Payment Breakdown by Category
Food & Beverage$11,168 (90.5%)
Education$1,175 (9.5%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $11,168 | 515 | 90.5% |
| Education | $1,175 | 31 | 9.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Astellas Pharma US Inc | $1,818 | 101 | $0 (2024) |
| COLOPLAST CORP | $869.53 | 36 | $0 (2024) |
| Teleflex LLC | $697.47 | 5 | $0 (2024) |
| Boston Scientific Corporation | $623.33 | 13 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $610.05 | 27 | $0 (2024) |
| Janssen Biotech, Inc. | $502.78 | 40 | $0 (2024) |
| Ferring Pharmaceuticals Inc. | $449.39 | 19 | $0 (2024) |
| ABBVIE INC. | $426.78 | 30 | $0 (2024) |
| UROGEN PHARMA, INC. | $397.94 | 22 | $0 (2024) |
| Axonics, Inc. | $374.51 | 7 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,058 | 69 | Axonics, Inc. ($286.21) |
| 2023 | $1,610 | 67 | Sumitomo Pharma America, Inc. ($150.17) |
| 2022 | $2,033 | 78 | Boston Scientific Corporation ($359.39) |
| 2021 | $1,123 | 53 | Astellas Pharma US Inc ($308.02) |
| 2020 | $1,176 | 59 | Astellas Pharma US Inc ($356.51) |
| 2019 | $1,386 | 70 | Astellas Pharma US Inc ($265.25) |
| 2018 | $1,743 | 77 | Coloplast Corp ($333.81) |
| 2017 | $1,215 | 73 | Coloplast Corp ($253.77) |
All Payment Transactions
546 individual payment records from CMS Open Payments — Page 1 of 22
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | Janssen Biotech, Inc. | ERLEADA (Drug) | Food and Beverage | In-kind items and services | $15.17 | General |
| Category: Oncology | ||||||
| 12/11/2024 | Ferring Pharmaceuticals Inc. | ADSTILADRIN (Biological) | Food and Beverage | In-kind items and services | $20.01 | General |
| Category: ONCOLOGY | ||||||
| 12/09/2024 | Novartis Pharmaceuticals Corporation | PLUVICTO (Drug) | Food and Beverage | In-kind items and services | $23.91 | General |
| Category: Oncology | ||||||
| 12/04/2024 | ACCORD HEALTHCARE, INC. | CAMCEVI (Drug) | Food and Beverage | In-kind items and services | $14.89 | General |
| Category: Oncology | ||||||
| 12/02/2024 | Sumitomo Pharma America, Inc. | ORGOVYX (Drug) | Food and Beverage | In-kind items and services | $20.00 | General |
| Category: HORMONE THERAPY | ||||||
| 11/19/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $31.92 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 11/13/2024 | Novartis Pharmaceuticals Corporation | PLUVICTO (Drug) | Food and Beverage | In-kind items and services | $21.68 | General |
| Category: Oncology | ||||||
| 11/12/2024 | UROGEN PHARMA, INC. | JELMYTO (Drug) | Food and Beverage | In-kind items and services | $18.13 | General |
| Category: UROTHELIAL CANCER | ||||||
| 11/11/2024 | Astellas Pharma US Inc | Xtandi (Drug) | Food and Beverage | In-kind items and services | $13.92 | General |
| Category: Oncology | ||||||
| 11/06/2024 | Merck Sharp & Dohme LLC | LYNPARZA (Biological) | Food and Beverage | In-kind items and services | $20.86 | General |
| Category: ONCOLOGY | ||||||
| 10/30/2024 | AngioDynamics, Inc. | NANOKNIFE (Device) | Food and Beverage | In-kind items and services | $15.35 | General |
| Category: OS | ||||||
| 10/29/2024 | ACCORD HEALTHCARE, INC. | CAMCEVI (Drug) | Food and Beverage | In-kind items and services | $18.64 | General |
| Category: Oncology | ||||||
| 10/23/2024 | Novartis Pharmaceuticals Corporation | PLUVICTO (Drug) | Food and Beverage | In-kind items and services | $22.06 | General |
| Category: Oncology | ||||||
| 10/21/2024 | HISTOSONICS,INC. | — | Food and Beverage | Cash or cash equivalent | $156.67 | General |
| 10/15/2024 | UROGEN PHARMA, INC. | JELMYTO (Drug) | Food and Beverage | In-kind items and services | $21.74 | General |
| Category: UROTHELIAL CANCER | ||||||
| 10/14/2024 | Teleflex LLC | UROLIFT (Device) | Food and Beverage | In-kind items and services | $149.83 | General |
| Category: INTERVENTIONAL UROLOGY | ||||||
| 10/02/2024 | Boston Scientific Corporation | AMS 700 (Device) | Food and Beverage | In-kind items and services | $22.24 | General |
| Category: AMS 700_URO | ||||||
| 09/25/2024 | Bayer Healthcare Pharmaceuticals Inc. | Nubeqa (Drug), Xofigo | Food and Beverage | In-kind items and services | $28.08 | General |
| Category: Oncology | ||||||
| 09/23/2024 | Ferring Pharmaceuticals Inc. | ADSTILADRIN (Biological) | Food and Beverage | In-kind items and services | $19.27 | General |
| Category: ONCOLOGY | ||||||
| 09/16/2024 | Sumitomo Pharma America, Inc. | ORGOVYX (Drug) | Food and Beverage | In-kind items and services | $18.57 | General |
| Category: HORMONE THERAPY | ||||||
| 09/11/2024 | ABBVIE INC. | LUPRON DEPOT (Drug) | Food and Beverage | In-kind items and services | $14.61 | General |
| Category: ENDOCRINOLOGY | ||||||
| 09/09/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | YONSA (Drug) | Food and Beverage | In-kind items and services | $21.23 | General |
| Category: Oncology | ||||||
| 09/09/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $19.56 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 08/27/2024 | Astellas Pharma US Inc | — | Education | In-kind items and services | $99.00 | General |
| 08/26/2024 | Axonics, Inc. | Axonics (Device) | Food and Beverage | In-kind items and services | $119.37 | General |
| Category: Urology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 32 | 2,688 | 3,493 | $1.0M | $161,125 |
| 2022 | 32 | 2,870 | 3,811 | $864,576 | $157,924 |
| 2021 | 36 | 3,059 | 3,740 | $901,024 | $161,089 |
| 2020 | 40 | 2,937 | 6,200 | $814,567 | $169,061 |
Total Patients
11,554
Total Services
17,244
Medicare Billing
$649,199
Procedure Codes
141
All Medicare Procedures & Services
141 procedure records from CMS Medicare Utilization — Page 1 of 6
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 525 | 664 | $164,902 | $54,496 | 33.0% |
| 52649 | Complete laser fragmentation of prostate including control of bleeding using an endoscope | Facility | 2023 | 46 | 46 | $390,000 | $28,059 | 7.2% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 55 | 306 | $63,036 | $13,821 | 21.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 110 | 110 | $43,044 | $11,615 | 27.0% |
| 55866 | Surgical removal of prostate and surrounding lymph nodes using an endoscope | Facility | 2023 | 12 | 12 | $95,336 | $10,822 | 11.4% |
| 84153 | Psa (prostate specific antigen) measurement, total | Office | 2023 | 286 | 343 | $24,353 | $6,101 | 25.1% |
| 51703 | Complicated insertion of bladder tube | Office | 2023 | 25 | 42 | $18,047 | $4,525 | 25.1% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Facility | 2023 | 62 | 64 | $39,990 | $3,336 | 8.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 52 | 53 | $10,711 | $3,130 | 29.2% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 288 | 364 | $11,631 | $3,011 | 25.9% |
| 55700 | Biopsy of prostate gland | Facility | 2023 | 27 | 27 | $15,801 | $2,694 | 17.0% |
| 81002 | Urinalysis, manual test | Office | 2023 | 592 | 754 | $18,680 | $2,547 | 13.6% |
| 52332 | Insertion of stent in ureter using an endoscope | Facility | 2023 | 18 | 21 | $27,429 | $2,430 | 8.9% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 20 | 20 | $6,333 | $1,806 | 28.5% |
| 86316 | Analysis for detection of tumor marker | Office | 2023 | 62 | 70 | $3,570 | $1,427 | 40.0% |
| 99211 | Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | Office | 2023 | 49 | 85 | $5,958 | $1,361 | 22.8% |
| 84154 | Psa (prostate specific antigen) measurement, free | Office | 2023 | 64 | 72 | $6,120 | $1,297 | 21.2% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 12 | 12 | $3,792 | $1,207 | 31.8% |
| 52281 | Dilation of urethra using an endoscope | Facility | 2023 | 11 | 11 | $9,823 | $1,191 | 12.1% |
| 84403 | Testosterone (hormone) level, total | Office | 2023 | 39 | 46 | $4,646 | $1,163 | 25.0% |
| 76872 | Ultrasound scan of pelvic region through rectum | Facility | 2023 | 48 | 48 | $14,976 | $1,136 | 7.6% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 16 | 19 | $2,823 | $1,098 | 38.9% |
| 51798 | Ultrasound measurement of bladder capacity after voiding | Office | 2023 | 108 | 124 | $11,638 | $841.22 | 7.2% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 13 | 15 | $1,680 | $574.95 | 34.2% |
| 96402 | Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | Office | 2023 | 11 | 14 | $2,114 | $344.82 | 16.3% |
About Dr. Michael Dusing, MD
Dr. Michael Dusing, MD is a Urology healthcare provider based in Crestview Hills, Kentucky. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/14/2007. The National Provider Identifier (NPI) number assigned to this provider is 1346373586.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Michael Dusing, MD has received a total of $12,343 in payments from pharmaceutical and medical device companies, with $2,058 received in 2024. These payments were reported across 546 transactions from 65 companies. The most common payment nature is "Food and Beverage" ($11,168).
As a Medicare-enrolled provider, Dusing has provided services to 11,554 Medicare beneficiaries, totaling 17,244 services with total Medicare billing of $649,199. Data is available for 4 years (2020–2023), covering 141 distinct procedure/service records.
Ad
Practice Information
- Specialty Urology
- Other Specialties Occupational Medicine
- Location Crestview Hills, KY
- Active Since 03/14/2007
- Last Updated 01/31/2013
- Taxonomy Code 208800000X
- Entity Type Individual
- NPI Number 1346373586
Products in Payments
- MYRBETRIQ (Drug) $556.65
- XTANDI (Drug) $552.44
- ORGOVYX (Drug) $492.60
- UroLift System (Device) $402.03
- SPEEDICATH (Device) $400.08
- JELMYTO (Drug) $397.94
- Axonics (Device) $363.42
- PROVENGE (Drug) $350.96
- General - Erectile Dysfunction (Device) $328.04
- Xofigo (Drug) $320.33
- Myrbetriq (Drug) $306.91
- iTIND System (Device) $297.97
- UROLIFT (Device) $295.44
- Nubeqa (Drug) $289.72
- FIRMAGON (Drug) $281.91
- CONTINENCE CARE (Device) $279.03
- ERLEADA (Drug) $268.80
- NOCDURNA (Drug) $234.75
- Erleada (Drug) $223.39
- UroLift (Device) $218.64
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Urology Doctors in Crestview Hills
Brian Shay, Md, MD
Urology — Payments: $26,798
Urology $26,798
Dr. Robert Larke, M.d, M.D
Urology — Payments: $21,814
Urology $21,814
Christopher Cirulli, Md, MD
Urology — Payments: $10,007
Urology $10,007
B Schwartz, Md, MD
Urology — Payments: $4,897
Urology $4,897
Christian Dewan
Urology — Payments: $1,339
Urology $1,339
James Williams, Md, MD
Urology — Payments: $150.80
Urology $150.80